We found a negative correlation between TIGIT positivity on T cells and PD-1 and LAG3 protein levels on tumor-infiltrating immune cells, supporting the hypothesis that TIGIT upregulation may compensate for low expression levels of other immune checkpoint proteins in RCC. The gene discussed is TIGIT; the disease is renal cell carcinoma.